VAPOURSOFT
LIVE

Serial Number

79302420

Owner

CONSORT MEDICAL LIMITED

Attorney

Charles P. Guarino

Filing Date

Dec 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

VAPOURSOFT Trademark

Serial Number: 79302420 • Registration: 6951809

VAPOURSOFT is a trademark filed by CONSORT MEDICAL LIMITED on December 14, 2020. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

CONSORT MEDICAL LIMITED (12 trademarks)

BERGEN WAY
KING'S LYNN, NORFOLK PE30 2JJ , GB

Entity Type: 24

Trademark Details

Filing Date

December 14, 2020

Registration Date

January 17, 2023

Published for Opposition

November 1, 2022

Goods & Services

Hydrofluoroalkanes (HFA) powered and liquefied gas powered apparatus and instruments for use in or in relation to drug and pharmaceutical delivery devices, namely, hydrofluoroalkanes (HFA) powered drug delivery systems in the nature of infusion and injection devices for administering drugs; hydrofluoralkanes (HFA) powered medical syringes, medical fluid auto-injectors for administering pharmaceuticals and drugs and apparatus and devices for the inhalation or injection of pharmaceuticals and drugs, namely, injection needles, medical fluid auto-injectors and syringes; hydrofluoralkanes (HFA) powered catheters, transfusion sets and injection syringes for administering drugs and pharmaceuticals, and also incorporating audio, visual and/or tactile patient feedback mechanisms relating to drug and pharmaceutical delivery dosage, measuring and monitoring information; hydrofluoralkanes (HFA) powered medical syringes, medical fluid auto-injectors, drug delivery systems comprised of implantable drug delivery ports incorporating audio, visual and/or tactile patient feedback mechanisms to convey dosage, measuring, and monitoring data for the purpose of facilitating and monitoring drug and pharmaceutical delivery and administration; medical syringes; medical syringe stoppers; hydrofluoroolefin (HFO) powered medical fluid auto-injectors and medical fluid injectors; hydrofluoroolefin (HFO) powered apparatus and devices for administering pharmaceuticals and drugs, namely, medical apparatus in the nature of infusion and injection devices for administering drugs, medical tubing for administering drugs, and hypodermic needles; hydrofluoroolefin (HFO) powered drug delivery apparatus, namely, drug delivery systems comprised of drug delivery catheters and electromagnetic drug delivery apparatus for medical use; medical fluid auto-injectors; medical fluid injectors; disposable syringes and medical fluid injectors; hypodermic syringes; apparatus and devices for administering pharmaceuticals and drugs, namely, medical apparatus in the nature of infusion and injection devices for administering drugs, medical tubing for administering drugs, and hypodermic needles; sterile medical syringes and medical fluid auto-injectors for the administration of pharmaceuticals and drugs; cartridges sold empty and specially adapted for medical syringes; nozzles sold empty and specially adapted for medical syringes; drug delivery apparatus, namely, drug delivery systems comprised of drug delivery catheters and electromagnetic drug delivery apparatus for medical use; oral and nasal medication dispensers, namely, aerosol dispensers for medical use; aerosol dispensers for medical purposes; structural replacement parts and fittings for all the aforesaid goods

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 11, 2025 NREP
INTERNATIONAL REGISTRATION RENEWED
Feb 29, 2024 RNWL
FINAL DECISION TRANSACTION PROCESSED BY IB
May 16, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 26, 2023 FICS
FINAL DISPOSITION PROCESSED
Apr 26, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 17, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 17, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 17, 2023 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 22, 2022 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Oct 31, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 12, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 12, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 12, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 7, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 7, 2022 TROA
REFUSAL PROCESSED BY IB
Apr 10, 2022 RFNT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 9, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 9, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 9, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2022 CRFA
ATTORNEY REVIEW COMPLETED
Feb 8, 2022 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Jan 12, 2022 CREV
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 16, 2021 TROA
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 3, 2021 CRCV
REFUSAL PROCESSED BY IB
Jul 18, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 21, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 21, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 12, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 11, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 7, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 23, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 19, 2021 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jan 14, 2021 SDRC